caris life sciences ipo - Search News

News

Life Sciences, Caris and IPO

The Dallas Morning News on MSN · 4d

Caris Life Sciences spikes by over 30% in IPO debut, embraces AI as future of oncology

The stock of Caris Life Sciences shined in its Nasdaq debut on Wednesday, pricing its heavily-subscribed initial public offering at $21 per share and

New Biotech Billionaire Minted In Caris Life Sciences IPO

The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion.

CNBC on MSN · 4d

Caris Life Sciences CEO on IPO debut, using AI to fight against cancer

David Dean Halbert, Caris Life Sciences chairman, founder and CEO, joins 'Squawk Box' to discuss the company's IPO debut, how the company uses AI technology to help diagnose and treat cancer,

5d

Caris Life Sciences Announces Pricing of Initial Public Offering

Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, ...

Caris swells its planned IPO, seeking $5.7bn valuation

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results